Effect of folic acid supplementation on diminished ovarian reserve: study protocol of a single-centre, open-label, randomised, placebo-controlled clinical trial

被引:4
作者
Liao, Kaijun [1 ]
Wang, Yan [2 ]
Zheng, Ling [1 ]
Lu, Dongli [1 ]
Wu, Jiaxin [1 ]
Wu, Binjin [1 ]
Wu, Zhaochun [1 ]
Jiang, Zhenghua [1 ]
机构
[1] Fujian Med Univ, Nanping Hosp 1, Dept Pharm, Nanping, Fujian, Peoples R China
[2] Fujian Med Univ, Nanping Hosp 1, Dept Gynecol & Obstet, Nanping, Fujian, Peoples R China
来源
BMJ OPEN | 2022年 / 12卷 / 07期
关键词
CLINICAL PHARMACOLOGY; Reproductive medicine; Subfertility; Protocols & guidelines; METABOLISM; FOLATE; WOMEN;
D O I
10.1136/bmjopen-2021-057689
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The prevalence of diminished ovarian reserve (DOR), a common gynaecological disorder, is approximately 10% across the world. Failure in early diagnosis and treatment may result in continuous decreases in ovarian function and the resultant loss in an opportunity of pregnancy, which greatly affects the happiness of the women's family and women's physical and mental health. Nevertheless, there has been no effective treatment for such a disorder until now. Folic acid, a member of the vitamin B family, is involved in one-carbon cycle and methylation regulation. It has been found that folic acid affects the whole period of pregnancy, and folic acid supplementation has shown effective to remarkably reduce the incidence of fetal neural tube defects and decrease plasma homocysteic acid levels, thereby resulting in a decline in the incidence of abortion. In addition, folic acid is reported to mediate ovarian functions. It is therefore hypothesised that folic acid may improve DOR. Methods and analysis A single-centre, open-label, randomised, placebo-controlled clinical trial is designed. We plan to recruit 140 women with DOR at ages of 30-35 years. All participants will be randomised into the folic acid group and placebo group, and each subject will be given a tablet with the same appearance daily for 6 months. The primary outcome is antral follicle count, and the secondary outcomes are ovarian reserve markers, ovarian low-dose stimulation responses and safety. Ethics and dissemination This study was approved by the Ethics Review Committee of Nanping First Hospital Affiliated to Fujian Medical University on 10 February 2021 (approval number: NPSY202002042). Written informed consent was obtained from all participants prior to randomisation, following a detailed description of the purpose of the study. The results of this clinical trial will be presented at scientific conferences and submitted to a peer-reviewed journal.
引用
收藏
页数:4
相关论文
共 22 条
[1]  
[Anonymous], 2016, J Midwifery Womens Health, V61, P797, DOI [10.1111/jmwh.12546, 10.1111/jmwh.12584]
[2]   Diminished ovarian reserve versus ovarian aging: overlaps and differences [J].
Ata, Baris ;
Seyhan, Ayse ;
Seli, Emre .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2019, 31 (03) :139-147
[3]   Folate metabolism and requirements [J].
Bailey, LB ;
Gregory, JF .
JOURNAL OF NUTRITION, 1999, 129 (04) :779-782
[4]  
Barros Francisco, 2020, Porto Biomed J, V5, pe62, DOI 10.1097/j.pbj.0000000000000062
[5]   The role of anti-Mullerian hormone (AMH) in ovarian disease and infertility [J].
Bedenk, Jure ;
Vrtacnik-Bokal, Eda ;
Virant-Klun, Irma .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (01) :89-100
[6]   Anti-Mullerian hormone as a predictor of reproductive potential [J].
Bressler, Leah Hawkins ;
Steiner, Anne .
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (06) :385-390
[7]   Diminished Ovarian Reserve. How Do You Diagnosis It? What Does It Mean? [J].
Cedars, Marcelle I. .
SEMINARS IN REPRODUCTIVE MEDICINE, 2013, 31 (06) :391-392
[8]   Counting ovarian antral follicles by ultrasound: a practical guide [J].
Coelho Neto, M. A. ;
Ludwin, A. ;
Borrell, A. ;
Benacerraf, B. ;
Dewailly, D. ;
da Silva Costa, F. ;
Condous, G. ;
Alcazar, J. L. ;
Jokubkiene, L. ;
Guerriero, S. ;
Van den Bosch, T. ;
Martins, W. P. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (01) :10-20
[9]   Diminished ovarian reserve, premature ovarian failure, poor ovarian responder-a plea for universal definitions [J].
Cohen, J. ;
Chabbert-Buffet, N. ;
Darai, E. .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2015, 32 (12) :1709-1712
[10]  
Cohen J, 2017, MINERVA GINECOL, V69, P315, DOI 10.23736/S0026-4784.16.04003-X